Supportive Shots: FDA, CDC Clear 3rd Pfizer, Moderna Vaccine

A woman receives a Biontech/Pfizer booster vaccine against the coronavirus at the vaccination center. Sven Hoppe Alliance / picture via Getty Images

The Food and Drug Administration and the Centers for Disease Control and Prevention on Friday authorized a third booster dose of the Pfizer-BioNTech and Moderna COVID-19 vaccine to be administered to all American adults.

Agencies recommend a dose of 30 mcg of Pfizer-BioNTech BNT162b2 or 50 mcg mRNA-1273 Moderna for everyone 18 years of age or older at least six months after initial mRNA sequencing or two months after receiving the Johnson & Johnson vaccine.

Food and Drug Administration clear shots For all adults on an emergency basis early Friday after reviewing new experimental data provided by Pfizer-BioNTech and Moderna. A third Pfizer booster is already authorized for use in people age 65 or younger who have underlying medical conditions or are at high risk of infection.

The Centers for Disease Control and Prevention (CDC) Immunization Practices Advisory Committee met Friday and voted unanimously to recommend a third booster under the FDA’s Emergency Use Authorization. The director of the Center for Disease Control, Dr. Rochelle Walinsky, on the advisory committee’s decision later on Friday.

Under the CDC’s recommendation:

  • Adults 50 years of age or older who have received an RNA-based vaccine Should Receiving a booster dose.
  • Adults between 18 and 49 years of age who live in long-term care facilities Should Receiving a booster dose.
  • Other adults between 18 and 49 years of age who have received an mRNA-based vaccine may be Receiving a booster dose.
  • All adults who have received the Johnson & Johnson vaccine Should Receive a booster injection.

“COVID-19 vaccines have proven to be the best and highly effective defense against COVID-19,” Acting FDA Commissioner Dr. Janet Woodcock said in a statement Friday. “Allowing the use of a single booster dose of the Moderna or Pfizer-BioNTech COVID-19 vaccine for individuals 18 years of age or older helps provide ongoing protection against COVID-19, including the severe consequences that can occur, such as hospitalization and the death.”

“I think it will be especially important to usher in the holiday season and the winter season,” Jamie Loehr, a member of the Centers for Disease Control and Prevention’s Immunization Advisory Committee, said in a statement after Friday’s vote. “I look forward to more data in the future on whether this is a booster dose or a third dose of the initial series. It will take months, if not years, to find out.”

More than 31 million people in the United States, about 16 percent of those fully vaccinated, have received an additional booster dose of the COVID-19 vaccine, according to CDC data.

FDA and CDC Clear 3rd Dose of Pfizer and Moderna COVID-19 Vaccine for All Adults

Add a Comment

Your email address will not be published. Required fields are marked *